tafamidis Archives -

Pfizer’s new drug for a rare heart disease – Vyndaqel – has shattered analysts’ sales forecasts in its

Vyndaqel romps away in US, spurring earnings hike from Pfizer

https://pharmaphorum.com/news/vyndaqel-romps-away-in-us-spurring-earnings-hike-from-pfizer/

The FDA has given a green light to two formulations of Pfizer’s tafamidis that have become the first

Pfizer claims FDA okay for rare heart disease drug tafamidis

https://pharmaphorum.com/news/pfizer-claims-fda-okay-for-rare-heart-disease-drug-tafamidis/

Pfizer is finally closing on approval of its rare disease therapy tafamidis in the US, several years after

Pfizer set for July FDA verdict on rare heart disease drug

https://pharmaphorum.com/news/pfizer-set-for-july-fda-verdict-on-rare-heart-disease-drug/

Pfizer’s heart disease drug, tafamidis, reduces mortality rates in patients, according to the top-line results of a phase

Pfizer drug reduces mortality in patients with fatal heart disease

https://pharmaphorum.com/news/tafamidis-reduces-mortality/

tafamidis